Benfluorex, Friends or Foe? The Effects of Benfluorex on Oxidative Status in the Brain During Experimental Diabetes
Abstract
Benfluorex is a pharmacological agent with antidiabetic and antihyperlipidemic properties. In this study, the brain's oxidative and non-enzymatic antioxidant status in diabetic and benfluorex administrated diabetic rats have been investigated. For the experimental procedures, three groups of 18 Wistar albino rats were used as the control, diabetes (induced by streptozotocin), and benfluorex treated diabetic rats (benfluorex administration intragastric 50 mg/kg daily for 21 days). Brain NOx, TBARS, GSH, AA levels, and MPO activity were determined spectrophotometrically. Benfluorex administration was caused that decreased lipid peroxidation and MPO activity while increased non-enzymatic antioxidant and NOx levels. These results showed that benfluorex treatment positively affects lipid peroxidation and non-enzymatic antioxidant status of the brain during diabetes.
Keywords
Benfluorex, brain, diabetes, lipid peroxidation, non-enzymatic antioxidants, nitric oxide.
References
- Aragno, M., Parola, S., Tamagno, E., Brignardello, E., Manti, R., Danni, O. & Boccuzzi, G. (2000). Oxidative derangement in rat synaptosomes induced by hyperglycemia: restorative effect of dehydroepiandrosterone treatment. Biochemistry & Pharmacology, 60(3):389-395. doi: 10.1016/s0006-2952(00)00327-0.
- Ates, O., Caylı, S.R., Altınoz, E., Altinoz, E., Kocak, A., Durak, M.A., Turkoz, Y. & Yologlu, S. (2007). Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats. Journal of Clinical Neuroscience, 14(3):256-260. doi: 10.1016/j.jocn.2005.12.010.
- Ates, O., Yucel, N., Cayli, S.R., Altinoz, E., Yologlu, S., Kocak, A., Cakir, C.O. & Turkoz, Y. (2006). Neuroprotective effect of etomidate in the central nervous system of streptozotocin-induced diabetic rats. Neurochemical Research, 31(6):777-783. doi: 10.1007/s11064-006-9076-0.
- Avogaro, A., Fadini, G.P. & Gallo, A. (2006). Endothelial dysfunction in type 2 diabetes mellitus. Nutrition, Metabolism and Cardiovascular Diseases, 16(1):39‐45. doi: 10.1016/j.numecd.2005.10.015.
- Aykac, A.G., Uysal, M., Yalcın, A.S., Koçak-Toker, N., Sivas, A. & Oz, H. (1985). The effect of chronic ethanol ingestion on hepatic lipid peroxide, glutathione, glutathione peroxidase and glutathione transferase in rats. Toxicology, 36(1):71-76. doi: 10.1016/0300-483x(85)90008-3.
- Berger, J., Shepart, D., Morrow, F. & Taylor, A. (1989). Relationship between dietary intake and tissue levels reduced and total vitamin C in nonscorbutic guinea pig. The Journal of Nutrition, 119(5):734-740. doi: 10.1093/jn/119.5.734.
- Bianchi, R., Bongers, V., Bravenboer, B. & Erkelens, D.W. (1993). Effects of benfluorex on insulin resistance and lipid metabolism in obese type II diabetic patients. Diabetes Care, 16(4):557-559. doi: 10.2337/diacare.16.4.557.
- Boutet, K., Frachon, I., Jobic, Y., Gut-Gobert, C., Leroyer, C., Carlhant-Kowalski, D., Sitbon, O., Simonneau, G. & Humbert, M. (2009). Fenfluramine-like cardiovascular side-effects of benfluorex. European Respiratory Journal, 33(3): 684-688. doi: 10.1183/09031936.00086308.
- Brindley, D.N., Akester, H., Derick, G.P., Irvine, C.D., Patmore, R.D., Spencer, H., Yule-Smith, A., Finnerty, C., Saxton, J., Macdonald, I.A. & et al. (1988). Effects of chronic administration of benfluorex to rats on the metabolism of corticosterone, glucose, triacylglycerol, glycerol and fatty acid. Biochemistry & Pharmacology, 37(4):695-705. doi: 10.1016/0006-2952(88)90144-x.
- Casini, A., Ferrali, M. & Pompella, A. (1986). Lipid peroxidation and cellular damage in extrahepatic tissue of bromobenzene-intoxicated mice. American Journal of Pathology, 123(3):520-531. PMID: 3717304
